Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature

NCT01778023 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Disorder
Idiopathic Short Stature

Interventions

DRUG: somatropin

Sponsor

Novo Nordisk A/S